NewslettersProstate Cell NewsThe Future of Patient-Derived Xenografts in Prostate Cancer ResearchBy Noshin Noorjahan - January 20, 20230146Although few prostate cancer patient-derived xenografts (PDXs) are available in large repositories, more PDXs are needed to reflect patient diversity, and to study new treatments and emerging mechanisms of resistance.[Nature Reviews Urology]Abstract